FIELD: biotechnology.
SUBSTANCE: invention refers to biotechnology, namely to production of cell lines used for cell technologies in medicine. Obtained new human embryonic rhabdomyosarcoma cell line 862 RMSar KDD exhibits stable culture and morphological characteristics, is stored in Specialized collection of vertebrate cell cultures of Russian collection of cell cultures under registration number RKKK (P) 791D. Cell line is characterized by expression of antigens of the main histocompatibility complex of I and II classes, overexpression of cancer-testicular genes GAGE, PASD1, PRAME, production of chemokine CCL2.
EFFECT: can be used to create biomedical cell products, cell models, to test activity of various pharmaceutical preparations, create diagnostic kits and test systems in order to develop new therapeutic approaches and drugs.
1 cl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| HUMAN SYNOVIAL SARCOMA CELL LINE 716 SS MNV | 2020 |
|
RU2740800C1 |
| MOUSE SPINDLE CELL SARCOMA CELL LINE 164 MSar FE | 2023 |
|
RU2796351C1 |
| HUMAN BLADDER CANCER CELL LINE 190 BICAN KAG | 2021 |
|
RU2779948C1 |
| HUMAN BLADDER CANCER CELL LINE 587 BLCAN TVV | 2020 |
|
RU2742244C1 |
| OSTEOGENIC HUMAN SARCOMA CELL LINE 793 OSSAR RVV | 2019 |
|
RU2722867C1 |
| HUMAN ALVEOLAR SARCOMA CELL LINE 9927 AIS SIO | 2022 |
|
RU2796356C1 |
| HUMAN BLADDER CANCER CELL LINE 398 BLCAN KAE | 2020 |
|
RU2742245C1 |
| HUMAN BLADDER CANCER CELL LINE 198 BLCAN RLA | 2019 |
|
RU2733230C1 |
| HUMAN OVARIAN CANCER CELL LINE 533 OOS | 2017 |
|
RU2650759C1 |
| APPLICATION OF CELL LINE OF RC291C CLEAR CELL ADENOCARCINOMA | 2018 |
|
RU2673729C1 |
